2367P A randomized phase II study of atezolizumab (atezo) plus recombinant human IL-7 (CYT107) vs. atezo alone in patients with locally advanced or metastatic urothelial carcinoma (mUC) Article Swipe

PDF

Russell K. Pachynski , Gurkamal Chatta , Rohit Jain , Helen Moon , Randy F. Sweis , S. Delacroix , Fang Tian , Steven P. Fling , André Lacroix , Judith C. Kaiser , Elad Sharon , Evan Y. Yu ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1016/j.annonc.2023.09.1016

Related Topics

Concepts

Atezolizumab Medicine Oncology Adverse effect Internal medicine Clinical endpoint Immunotherapy Clinical trial Nivolumab Cancer

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1016/j.annonc.2023.09.1016
PDF: http://www.annalsofoncology.org/article/S0923753423018525/pdf
OA Status: bronze
Cited By: 1
References: 2
Related Works: 10
OpenAlex ID: https://openalex.org/W4387807097

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4387807097

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1016/j.annonc.2023.09.1016

Digital Object Identifier
Title: 2367P A randomized phase II study of atezolizumab (atezo) plus recombinant human IL-7 (CYT107) vs. atezo alone in patients with locally advanced or metastatic urothelial carcinoma (mUC)

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-10-01

Full publication date if available
Authors: Russell K. Pachynski, Gurkamal Chatta, Rohit Jain, Helen Moon, Randy F. Sweis, S. Delacroix, Fang Tian, Steven P. Fling, André Lacroix, Judith C. Kaiser, Elad Sharon, Evan Y. Yu

List of authors in order
Landing page: https://doi.org/10.1016/j.annonc.2023.09.1016

Publisher landing page
PDF URL: https://www.annalsofoncology.org/article/S0923753423018525/pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: bronze

Open access status per OpenAlex
OA URL: https://www.annalsofoncology.org/article/S0923753423018525/pdf

Direct OA link when available
Concepts: Atezolizumab, Medicine, Oncology, Adverse effect, Internal medicine, Clinical endpoint, Immunotherapy, Clinical trial, Nivolumab, Cancer

Top concepts (fields/topics) attached by OpenAlex
Cited by: 1

Total citation count in OpenAlex
Citations by year (recent): 2023: 1

Per-year citation counts (last 5 years)
References (count): 2

Number of works referenced by this work
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4387807097
doi	https://doi.org/10.1016/j.annonc.2023.09.1016
ids.doi	https://doi.org/10.1016/j.annonc.2023.09.1016
ids.openalex	https://openalex.org/W4387807097
fwci	0.23759703
type	article
title	2367P A randomized phase II study of atezolizumab (atezo) plus recombinant human IL-7 (CYT107) vs. atezo alone in patients with locally advanced or metastatic urothelial carcinoma (mUC)
biblio.issue
biblio.volume	34
biblio.last_page	S1205
biblio.first_page	S1204
topics[0].id	https://openalex.org/T10158
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9993000030517578
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2730
topics[0].subfield.display_name	Oncology
topics[0].display_name	Cancer Immunotherapy and Biomarkers
topics[1].id	https://openalex.org/T10458
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9975000023841858
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2746
topics[1].subfield.display_name	Surgery
topics[1].display_name	Bladder and Urothelial Cancer Treatments
topics[2].id	https://openalex.org/T10580
topics[2].field.id	https://openalex.org/fields/24
topics[2].field.display_name	Immunology and Microbiology
topics[2].score	0.9948999881744385
topics[2].domain.id	https://openalex.org/domains/1
topics[2].domain.display_name	Life Sciences
topics[2].subfield.id	https://openalex.org/subfields/2403
topics[2].subfield.display_name	Immunology
topics[2].display_name	Immunotherapy and Immune Responses
funders[0].id	https://openalex.org/F4320307115
funders[0].ror	https://ror.org/00gtmwv55
funders[0].display_name	Bristol-Myers Squibb
funders[1].id	https://openalex.org/F4320307758
funders[1].ror	https://ror.org/01qat3289
funders[1].display_name	Eli Lilly and Company
funders[2].id	https://openalex.org/F4320307765
funders[2].ror	https://ror.org/01xdqrp08
funders[2].display_name	Pfizer
funders[3].id	https://openalex.org/F4320307770
funders[3].ror	https://ror.org/04r9x1a08
funders[3].display_name	AstraZeneca
funders[4].id	https://openalex.org/F4320322148
funders[4].ror	https://ror.org/04vvh7p27
funders[4].display_name	Eisai
funders[5].id	https://openalex.org/F4320323024
funders[5].ror	https://ror.org/01cjash87
funders[5].display_name	Astellas Pharma
funders[6].id	https://openalex.org/F4320328455
funders[6].ror	https://ror.org/00d801g55
funders[6].display_name	Ipsen
funders[7].id	https://openalex.org/F4320332193
funders[7].ror	https://ror.org/04gndp242
funders[7].display_name	Genentech
is_xpac	False
apc_list.value	4060
apc_list.currency	USD
apc_list.value_usd	4060
apc_paid
concepts[0].id	https://openalex.org/C2775949291
concepts[0].level	5
concepts[0].score	0.9484567642211914
concepts[0].wikidata	https://www.wikidata.org/wiki/Q20707748
concepts[0].display_name	Atezolizumab
concepts[1].id	https://openalex.org/C71924100
concepts[1].level	0
concepts[1].score	0.9220340251922607
concepts[1].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[1].display_name	Medicine
concepts[2].id	https://openalex.org/C143998085
concepts[2].level	1
concepts[2].score	0.5798853635787964
concepts[2].wikidata	https://www.wikidata.org/wiki/Q162555
concepts[2].display_name	Oncology
concepts[3].id	https://openalex.org/C197934379
concepts[3].level	2
concepts[3].score	0.5412428379058838
concepts[3].wikidata	https://www.wikidata.org/wiki/Q2047938
concepts[3].display_name	Adverse effect
concepts[4].id	https://openalex.org/C126322002
concepts[4].level	1
concepts[4].score	0.5243268609046936
concepts[4].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[4].display_name	Internal medicine
concepts[5].id	https://openalex.org/C203092338
concepts[5].level	3
concepts[5].score	0.4954153299331665
concepts[5].wikidata	https://www.wikidata.org/wiki/Q1340863
concepts[5].display_name	Clinical endpoint
concepts[6].id	https://openalex.org/C2777701055
concepts[6].level	3
concepts[6].score	0.46440696716308594
concepts[6].wikidata	https://www.wikidata.org/wiki/Q1427096
concepts[6].display_name	Immunotherapy
concepts[7].id	https://openalex.org/C535046627
concepts[7].level	2
concepts[7].score	0.37639275193214417
concepts[7].wikidata	https://www.wikidata.org/wiki/Q30612
concepts[7].display_name	Clinical trial
concepts[8].id	https://openalex.org/C2780030458
concepts[8].level	4
concepts[8].score	0.24511447548866272
concepts[8].wikidata	https://www.wikidata.org/wiki/Q7041828
concepts[8].display_name	Nivolumab
concepts[9].id	https://openalex.org/C121608353
concepts[9].level	2
concepts[9].score	0.22106614708900452
concepts[9].wikidata	https://www.wikidata.org/wiki/Q12078
concepts[9].display_name	Cancer
keywords[0].id	https://openalex.org/keywords/atezolizumab
keywords[0].score	0.9484567642211914
keywords[0].display_name	Atezolizumab
keywords[1].id	https://openalex.org/keywords/medicine
keywords[1].score	0.9220340251922607
keywords[1].display_name	Medicine
keywords[2].id	https://openalex.org/keywords/oncology
keywords[2].score	0.5798853635787964
keywords[2].display_name	Oncology
keywords[3].id	https://openalex.org/keywords/adverse-effect
keywords[3].score	0.5412428379058838
keywords[3].display_name	Adverse effect
keywords[4].id	https://openalex.org/keywords/internal-medicine
keywords[4].score	0.5243268609046936
keywords[4].display_name	Internal medicine
keywords[5].id	https://openalex.org/keywords/clinical-endpoint
keywords[5].score	0.4954153299331665
keywords[5].display_name	Clinical endpoint
keywords[6].id	https://openalex.org/keywords/immunotherapy
keywords[6].score	0.46440696716308594
keywords[6].display_name	Immunotherapy
keywords[7].id	https://openalex.org/keywords/clinical-trial
keywords[7].score	0.37639275193214417
keywords[7].display_name	Clinical trial
keywords[8].id	https://openalex.org/keywords/nivolumab
keywords[8].score	0.24511447548866272
keywords[8].display_name	Nivolumab
keywords[9].id	https://openalex.org/keywords/cancer
keywords[9].score	0.22106614708900452
keywords[9].display_name	Cancer
language	en
locations[0].id	doi:10.1016/j.annonc.2023.09.1016
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S41454044
locations[0].source.issn	0923-7534, 1569-8041
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	0923-7534
locations[0].source.is_core	True
locations[0].source.is_in_doaj	False
locations[0].source.display_name	Annals of Oncology
locations[0].source.host_organization	https://openalex.org/P4310320990
locations[0].source.host_organization_name	Elsevier BV
locations[0].source.host_organization_lineage	https://openalex.org/P4310320990
locations[0].license
locations[0].pdf_url	http://www.annalsofoncology.org/article/S0923753423018525/pdf
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Annals of Oncology
locations[0].landing_page_url	https://doi.org/10.1016/j.annonc.2023.09.1016
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5083027775
authorships[0].author.orcid	https://orcid.org/0000-0002-8966-7631
authorships[0].author.display_name	Russell K. Pachynski
authorships[0].countries	US
authorships[0].affiliations[0].institution_ids	https://openalex.org/I204465549
authorships[0].affiliations[0].raw_affiliation_string	Medicine/Oncology Department, Washington University School of Medicine in St. Louis, St. Louis, MO, USA
authorships[0].institutions[0].id	https://openalex.org/I204465549
authorships[0].institutions[0].ror	https://ror.org/01yc7t268
authorships[0].institutions[0].type	education
authorships[0].institutions[0].lineage	https://openalex.org/I204465549
authorships[0].institutions[0].country_code	US
authorships[0].institutions[0].display_name	Washington University in St. Louis
authorships[0].author_position	first
authorships[0].raw_author_name	R. Pachynski
authorships[0].is_corresponding	False
authorships[0].raw_affiliation_strings	Medicine/Oncology Department, Washington University School of Medicine in St. Louis, St. Louis, MO, USA
authorships[1].author.id	https://openalex.org/A5089256383
authorships[1].author.orcid	https://orcid.org/0000-0002-3154-9042
authorships[1].author.display_name	Gurkamal Chatta
authorships[1].countries	US
authorships[1].affiliations[0].institution_ids	https://openalex.org/I1292894508
authorships[1].affiliations[0].raw_affiliation_string	Oncology Department, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
authorships[1].institutions[0].id	https://openalex.org/I1292894508
authorships[1].institutions[0].ror	https://ror.org/0499dwk57
authorships[1].institutions[0].type	facility
authorships[1].institutions[0].lineage	https://openalex.org/I1292894508
authorships[1].institutions[0].country_code	US
authorships[1].institutions[0].display_name	Roswell Park Comprehensive Cancer Center
authorships[1].author_position	middle
authorships[1].raw_author_name	G. Chatta
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Oncology Department, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
authorships[2].author.id	https://openalex.org/A5023152191
authorships[2].author.orcid	https://orcid.org/0000-0002-4905-462X
authorships[2].author.display_name	Rohit Jain
authorships[2].countries	US
authorships[2].affiliations[0].institution_ids	https://openalex.org/I3019308854
authorships[2].affiliations[0].raw_affiliation_string	Genitourinary Oncology Department, H. Lee Moffitt Cancer Center & Research Institute - Magnolia Campus, Tampa, FL, USA
authorships[2].institutions[0].id	https://openalex.org/I3019308854
authorships[2].institutions[0].ror	https://ror.org/01xf75524
authorships[2].institutions[0].type	healthcare
authorships[2].institutions[0].lineage	https://openalex.org/I3019308854
authorships[2].institutions[0].country_code	US
authorships[2].institutions[0].display_name	Moffitt Cancer Center
authorships[2].author_position	middle
authorships[2].raw_author_name	R.K. Jain
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	Genitourinary Oncology Department, H. Lee Moffitt Cancer Center & Research Institute - Magnolia Campus, Tampa, FL, USA
authorships[3].author.id	https://openalex.org/A5112689275
authorships[3].author.orcid
authorships[3].author.display_name	Helen Moon
authorships[3].countries	US
authorships[3].affiliations[0].institution_ids	https://openalex.org/I4210113696
authorships[3].affiliations[0].raw_affiliation_string	Oncology Department, Kaiser Permanente - Riverside Medical Center, Riverside, CA, USA
authorships[3].institutions[0].id	https://openalex.org/I4210113696
authorships[3].institutions[0].ror	https://ror.org/01wgych27
authorships[3].institutions[0].type	healthcare
authorships[3].institutions[0].lineage	https://openalex.org/I1343052199, https://openalex.org/I4210113696
authorships[3].institutions[0].country_code	US
authorships[3].institutions[0].display_name	Kaiser Permanente Riverside Medical Center
authorships[3].author_position	middle
authorships[3].raw_author_name	H. Moon
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Oncology Department, Kaiser Permanente - Riverside Medical Center, Riverside, CA, USA
authorships[4].author.id	https://openalex.org/A5073289880
authorships[4].author.orcid	https://orcid.org/0000-0002-0497-9637
authorships[4].author.display_name	Randy F. Sweis
authorships[4].countries	US
authorships[4].affiliations[0].institution_ids	https://openalex.org/I40347166
authorships[4].affiliations[0].raw_affiliation_string	Medicine, The University of Chicago, Chicago, IL, USA
authorships[4].institutions[0].id	https://openalex.org/I40347166
authorships[4].institutions[0].ror	https://ror.org/024mw5h28
authorships[4].institutions[0].type	education
authorships[4].institutions[0].lineage	https://openalex.org/I40347166
authorships[4].institutions[0].country_code	US
authorships[4].institutions[0].display_name	University of Chicago
authorships[4].author_position	middle
authorships[4].raw_author_name	R. Sweis
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	Medicine, The University of Chicago, Chicago, IL, USA
authorships[5].author.id	https://openalex.org/A5069578951
authorships[5].author.orcid
authorships[5].author.display_name	S. Delacroix
authorships[5].countries	US
authorships[5].affiliations[0].institution_ids	https://openalex.org/I121820613, https://openalex.org/I75420490
authorships[5].affiliations[0].raw_affiliation_string	Urology, Louisiana State University School of Medicine and Stanley S. Scott Cancer Center, New Orleans, LA, USA
authorships[5].institutions[0].id	https://openalex.org/I121820613
authorships[5].institutions[0].ror	https://ror.org/05ect4e57
authorships[5].institutions[0].type	education
authorships[5].institutions[0].lineage	https://openalex.org/I121820613
authorships[5].institutions[0].country_code	US
authorships[5].institutions[0].display_name	Louisiana State University
authorships[5].institutions[1].id	https://openalex.org/I75420490
authorships[5].institutions[1].ror	https://ror.org/01qv8fp92
authorships[5].institutions[1].type	education
authorships[5].institutions[1].lineage	https://openalex.org/I75420490
authorships[5].institutions[1].country_code	US
authorships[5].institutions[1].display_name	Louisiana State University Health Sciences Center New Orleans
authorships[5].author_position	middle
authorships[5].raw_author_name	S. Delacroix
authorships[5].is_corresponding	False
authorships[5].raw_affiliation_strings	Urology, Louisiana State University School of Medicine and Stanley S. Scott Cancer Center, New Orleans, LA, USA
authorships[6].author.id	https://openalex.org/A5100439059
authorships[6].author.orcid	https://orcid.org/0000-0003-3153-2336
authorships[6].author.display_name	Fang Tian
authorships[6].countries	US
authorships[6].affiliations[0].institution_ids	https://openalex.org/I95746587
authorships[6].affiliations[0].raw_affiliation_string	PBS, Cytel Inc., Cambridge, MA, USA
authorships[6].institutions[0].id	https://openalex.org/I95746587
authorships[6].institutions[0].ror	https://ror.org/01ftkxq60
authorships[6].institutions[0].type	company
authorships[6].institutions[0].lineage	https://openalex.org/I95746587
authorships[6].institutions[0].country_code	US
authorships[6].institutions[0].display_name	Cytel (United States)
authorships[6].author_position	middle
authorships[6].raw_author_name	T. Fang
authorships[6].is_corresponding	False
authorships[6].raw_affiliation_strings	PBS, Cytel Inc., Cambridge, MA, USA
authorships[7].author.id	https://openalex.org/A5023766816
authorships[7].author.orcid	https://orcid.org/0000-0001-6263-0153
authorships[7].author.display_name	Steven P. Fling
authorships[7].countries	US
authorships[7].affiliations[0].institution_ids	https://openalex.org/I4210089486
authorships[7].affiliations[0].raw_affiliation_string	Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
authorships[7].institutions[0].id	https://openalex.org/I4210089486
authorships[7].institutions[0].ror	https://ror.org/007ps6h72
authorships[7].institutions[0].type	nonprofit
authorships[7].institutions[0].lineage	https://openalex.org/I4210089486
authorships[7].institutions[0].country_code	US
authorships[7].institutions[0].display_name	Fred Hutch Cancer Center
authorships[7].author_position	middle
authorships[7].raw_author_name	S.P. Fling
authorships[7].is_corresponding	False
authorships[7].raw_affiliation_strings	Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
authorships[8].author.id	https://openalex.org/A5012064746
authorships[8].author.orcid	https://orcid.org/0000-0003-4137-3025
authorships[8].author.display_name	André Lacroix
authorships[8].countries	US
authorships[8].affiliations[0].institution_ids	https://openalex.org/I4210089486
authorships[8].affiliations[0].raw_affiliation_string	VIDD, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
authorships[8].institutions[0].id	https://openalex.org/I4210089486
authorships[8].institutions[0].ror	https://ror.org/007ps6h72
authorships[8].institutions[0].type	nonprofit
authorships[8].institutions[0].lineage	https://openalex.org/I4210089486
authorships[8].institutions[0].country_code	US
authorships[8].institutions[0].display_name	Fred Hutch Cancer Center
authorships[8].author_position	middle
authorships[8].raw_author_name	A. Lacroix
authorships[8].is_corresponding	False
authorships[8].raw_affiliation_strings	VIDD, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
authorships[9].author.id	https://openalex.org/A5008592962
authorships[9].author.orcid	https://orcid.org/0000-0001-7165-7200
authorships[9].author.display_name	Judith C. Kaiser
authorships[9].countries	US
authorships[9].affiliations[0].institution_ids	https://openalex.org/I4210089486
authorships[9].affiliations[0].raw_affiliation_string	VIDD, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
authorships[9].institutions[0].id	https://openalex.org/I4210089486
authorships[9].institutions[0].ror	https://ror.org/007ps6h72
authorships[9].institutions[0].type	nonprofit
authorships[9].institutions[0].lineage	https://openalex.org/I4210089486
authorships[9].institutions[0].country_code	US
authorships[9].institutions[0].display_name	Fred Hutch Cancer Center
authorships[9].author_position	middle
authorships[9].raw_author_name	J. Kaiser
authorships[9].is_corresponding	False
authorships[9].raw_affiliation_strings	VIDD, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
authorships[10].author.id	https://openalex.org/A5022594161
authorships[10].author.orcid	https://orcid.org/0000-0002-0044-9719
authorships[10].author.display_name	Elad Sharon
authorships[10].countries	US
authorships[10].affiliations[0].institution_ids	https://openalex.org/I4210140884
authorships[10].affiliations[0].raw_affiliation_string	Division of Cancer Treatment & Diagnosis, National Cancer Institute, Bethesda, MD, USA
authorships[10].institutions[0].id	https://openalex.org/I4210140884
authorships[10].institutions[0].ror	https://ror.org/040gcmg81
authorships[10].institutions[0].type	government
authorships[10].institutions[0].lineage	https://openalex.org/I1299022934, https://openalex.org/I1299303238, https://openalex.org/I4210140884
authorships[10].institutions[0].country_code	US
authorships[10].institutions[0].display_name	National Cancer Institute
authorships[10].author_position	middle
authorships[10].raw_author_name	E. Sharon
authorships[10].is_corresponding	False
authorships[10].raw_affiliation_strings	Division of Cancer Treatment & Diagnosis, National Cancer Institute, Bethesda, MD, USA
authorships[11].author.id	https://openalex.org/A5084909001
authorships[11].author.orcid	https://orcid.org/0000-0002-1510-8044
authorships[11].author.display_name	Evan Y. Yu
authorships[11].countries	US
authorships[11].affiliations[0].institution_ids	https://openalex.org/I201448701, https://openalex.org/I4210089486
authorships[11].affiliations[0].raw_affiliation_string	Medicine/Oncology Department, Fred Hutchinson Cancer Center and University of Washington, Seattle, WA, USA
authorships[11].institutions[0].id	https://openalex.org/I4210089486
authorships[11].institutions[0].ror	https://ror.org/007ps6h72
authorships[11].institutions[0].type	nonprofit
authorships[11].institutions[0].lineage	https://openalex.org/I4210089486
authorships[11].institutions[0].country_code	US
authorships[11].institutions[0].display_name	Fred Hutch Cancer Center
authorships[11].institutions[1].id	https://openalex.org/I201448701
authorships[11].institutions[1].ror	https://ror.org/00cvxb145
authorships[11].institutions[1].type	education
authorships[11].institutions[1].lineage	https://openalex.org/I201448701
authorships[11].institutions[1].country_code	US
authorships[11].institutions[1].display_name	University of Washington
authorships[11].author_position	last
authorships[11].raw_author_name	E. Yu
authorships[11].is_corresponding	False
authorships[11].raw_affiliation_strings	Medicine/Oncology Department, Fred Hutchinson Cancer Center and University of Washington, Seattle, WA, USA
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	http://www.annalsofoncology.org/article/S0923753423018525/pdf
open_access.oa_status	bronze
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	2367P A randomized phase II study of atezolizumab (atezo) plus recombinant human IL-7 (CYT107) vs. atezo alone in patients with locally advanced or metastatic urothelial carcinoma (mUC)
has_fulltext	True
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10158
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9993000030517578
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2730
primary_topic.subfield.display_name	Oncology
primary_topic.display_name	Cancer Immunotherapy and Biomarkers
related_works	https://openalex.org/W4248636606, https://openalex.org/W3024972238, https://openalex.org/W4388045576, https://openalex.org/W2186633408, https://openalex.org/W2788599721, https://openalex.org/W2706973099, https://openalex.org/W2955392295, https://openalex.org/W2890508535, https://openalex.org/W4242345934, https://openalex.org/W3091399767
cited_by_count	1
counts_by_year[0].year	2023
counts_by_year[0].cited_by_count	1
locations_count	1
best_oa_location.id	doi:10.1016/j.annonc.2023.09.1016
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S41454044
best_oa_location.source.issn	0923-7534, 1569-8041
best_oa_location.source.type	journal
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l	0923-7534
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	Annals of Oncology
best_oa_location.source.host_organization	https://openalex.org/P4310320990
best_oa_location.source.host_organization_name	Elsevier BV
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310320990
best_oa_location.license
best_oa_location.pdf_url	http://www.annalsofoncology.org/article/S0923753423018525/pdf
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Annals of Oncology
best_oa_location.landing_page_url	https://doi.org/10.1016/j.annonc.2023.09.1016
primary_location.id	doi:10.1016/j.annonc.2023.09.1016
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S41454044
primary_location.source.issn	0923-7534, 1569-8041
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	0923-7534
primary_location.source.is_core	True
primary_location.source.is_in_doaj	False
primary_location.source.display_name	Annals of Oncology
primary_location.source.host_organization	https://openalex.org/P4310320990
primary_location.source.host_organization_name	Elsevier BV
primary_location.source.host_organization_lineage	https://openalex.org/P4310320990
primary_location.license
primary_location.pdf_url	http://www.annalsofoncology.org/article/S0923753423018525/pdf
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Annals of Oncology
primary_location.landing_page_url	https://doi.org/10.1016/j.annonc.2023.09.1016
publication_date	2023-10-01
publication_year	2023
referenced_works	https://openalex.org/W4387807093, https://openalex.org/W4387807097
referenced_works_count	2
abstract_inverted_index
cited_by_percentile_year.max	94
cited_by_percentile_year.min	89
countries_distinct_count	1
institutions_distinct_count	12
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.7599999904632568
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.70636404
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False